AMY VAN DE WIELLE: Open Payments
NPI 1144953902 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 42 payments from 14 companies in 2025. Trend: 2023 $289 · 2024 $709 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $424 |
| Phathom Pharmaceuticals, Inc. | 3 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Madrigal Pharmaceuticals | 3 | $76 |
| Ardelyx, Inc. | 4 | $69 |
| ABBVIE INC. | 3 | $49 |
| Gilead Sciences, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: TREMFYA, VOQUEZNA, ENTYVIO, REZDIFFRA, IBSRELA, LINZESS, VOWST, OCALIVA.
Industry payments across IN — which companies pay providers there.
